Attenuation of formalin-induced nociceptive behaviors following local peripheral injection of gabapentin

Pain

Volumn 76, Issue 1-2, 1998, Pages 201-207

  Carlton, Susan M ^a   Zhou, Shengtai ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

D Serine; Hyperalgesia; Neurontin; Nociception

Indexed keywords

GABAPENTIN;

ANALGESIA; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL REFLEX;

ACETIC ACIDS; AMINES; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, SUBCUTANEOUS; MALE; NOCICEPTORS; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SERINE;

EID: 0031746097     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00043-8     Document Type: Article

References (41)

1. Bartoszyk, G.D. and Reimann, W., Preclinical characterization of the anticonvulsant gabapentin. In: 16th Epilepsy International Congress, 1985 (Abstract). (Ciba-Geigy, Basel, Switzerland).
2. Brugger F., Wicki U., Nassenstein-Elton D., Fagg G.E., Olpe H.-R., Pozza M.F. Modulation of the NMDA receptor by D-serine in the cortex and the spinal cord, in vitro. Eur. J. Pharmacol. 191:1990;29-38.
3. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci. Lett. 197:1995;25-28.
4. Coderre T.J., Vaccarino A.L., Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535:1990;155-158.
5. Dickenson A.H., Sullivan A.F. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 83:1987;207-211.
6. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
7. Field, M.J., Holloman, E.F., McCleary, S., Hughes, J. and Singh, L., Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain, J. PET., 282 (1997a) 1242-1246.
8. Field, M.J., Oles, R.J., Lewis, A.S., McCleary, S., Hughes, J. and Singh, L., Gabapentin (Neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents, Br. J. Pharmacol., 121 (1997b) 1513-1522.
9. Gao K.L., Sorkin E.M. Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs. 46:1993;409-427.
10. 2δ subunit of a calcium channel. J. Biol. Chem. 271:1996;5768-5776.
11. Goldlust A., Su T.-Z., Welty D.F., Taylor C.P., Oxender D.L. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res. 22:1995;1-11.
12. Haley J., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
13. Heapy C.G., Jamieson A., Russell N.J.W. Afferent C-fibre and Aδ activity in models of inflammation. Br. J. Pharmacol. 90:1987;164P.
14. 3H]gabapentin to a novel site in rat brain: autoradiographic studies. Eur. J. Pharmacol. 244:1993;303-309.
15. 2+ channel diversity. Annu. Rev. Neurosci. 17:1994;399-418.
16. Houghton, A.K., Lu, Y. and Westlund, K.N., S-(+)-3-isobutylgaba reduces the amount of inflammation and hyperalgesia in an acute arthritis model in the rat, J. Pharmacol. Exp. Ther. (1998) in press.
17. Hwang J.H., Yaksh T.L. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg. Anesth. 22:1997;249-256.
18. Isom L.L., De Jongh K.S., Catterall W.A. Auxiliary subunits of voltage-gated ion channels. Neuron. 12:1994;1183-1194.
19. Jun, J.H. and Yaksh, T.L., Effect of intrathecal gabapentin and 3isobutyl GABA on the hyperalgesia observed after thermal injury in the rat, Anesth. Analg., 86 (1998) 348-354.
20. Klemm F., Carli G., Reeh P.W. Peripheral neural correlates of the formalin test in the rat. Pflugers. Arch. 414:1989;S42.
21. 2- of NMDA responses in spinal cord neurons. Nature. 309:1984;261.
22. Mellick G.A., Mellicy L.B. Gabapentin in the management of reflex sympathetic dystrophy. J. Pain Symptom Manage. 10:1995;265-266.
23. Mellick L.B., Mellick G.A. Successful treatment of reflex sympathetic dystrophy with gabapentin. Am. J. Emerg. Med. 13:1995;96.
24. Oles R.J., Singh L., Hughes J., Woodruff G.N. The anticonvulsant action of gabapentin involves the glycine/NMDA receptor. Soc. Neurosci. Abstr. 6:1990;783.
25. Partridge, B., Chaplan, S.R., Sakamoto, E. and Yaksh, T.L., Characterization of the effects of gabapentin and 3-isobutyl-GABA on substance P-induced thermal hyperalgesia, Anesthesiology, 18 (1998) 96-205.
26. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1996;345-355.
27. 3H]MK 801 binding to NMDA receptor-ion channel complex by L-glutamate, glycine and polyamines. J. Neurochem. 51:1988;830-836.
28. Rock D.M., Kelly K.M., Macdonald R.L. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 16:1993;89-98.
29. Rosner H., Rubin L., Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin. J. Pain. 12:1996;5658.
30. 2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons. J. Neurosci. 12:1992;1789-1801.
31. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., Woodruff G.N. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology. 127:1996;1-9.
32. Stanfa L.C., Singh L., Williams R.G., Dickenson A.H. Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. NeuroReport. 8:1997;587-590.
33. Su T.Z., Lunney E., Campbell G., Oxender C.L. Transport of gabapentin, a gamma-amino acid drug, by system I alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J. Neurochem. 64:1995;2125-2131.
34. 3Hlgabapentin binding to a novel site in rat brain: homogenate binding studies. Eur. J. Pharmacol. Mol. Pharm. Sec. 244:1993;293-301.
35. Taylor, C.P., Mechanism of action of new anti-epileptic drugs. In: D. Chadwick (Ed.), New Trends in Epilepsy Management: The Role of Gabapentin, Royal Soc. of Med. Serv., London, 1993, pp. 13-40.
36. Taylor, C.P., Gabapentin: mechanisms of action. In: R.H Levy, R.H. Mattson and B.S. Meldrum (Eds.), Antiepileptic Drugs, Vol. 4, Raven Press, New York, 1995, pp. 829-841.
37. Taylor, C.P., Gee, N.S., Su, T.-Z., Kocsis, J., Welty, D., Brown, J.P., Dooley, D.J., Boden, P. and Singh, L., A summary of mechanistic hypotheses of gabapentin pharmacology, Epilepsy Res., (1998) in press.
38. Taylor C.P., Vartanian M.G., Yuen P.-W., Bigge C., Suman Chauhan N., Hill D.R. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 14:1993;11-15.
39. Vollmer K.-O., von Hodenberg A., Kolle E.U. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneim. Forsch./Drug Res. 36:1986;830-839.
40. Xiao W.-H., Bennett G.J. Gabapentin relieves abnormal pain sensations via a spinal site of action in a rat model of painful peripheral neuropathy. Analgesia. 2:1996;267-273.
41. Zhou S., Bonasera L., Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. NeuroReport. 7:1996;895-900.